Our call of the day from Nationwide Investment Management Group's chief market strategist, Mark Hackett, discusses the fierce battle that's been ongoing between institutional and retail investors. He ...

Healthcare royalties company Royalty Pharma (NASDAQ:RPRX) fell short of the market’s revenue expectations in Q2 CY2025, but ...

In this podcast, Motley Fool analyst Emily Flippen and contributors Travis Hoium and Lou Whiteman discuss: Meme stock mania ...